We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

214 hedge funds and large institutions have $3.46B invested in Adaptive Biotechnologies in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 69 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

442% more call options, than puts

Call options by funds: $6.41M | Put options by funds: $1.18M

10% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 69

3.75% more ownership

Funds ownership: 83.73% → 87.48% (+3.7%)

9% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 32

2% less funds holding

Funds holding: 219 → 214 (-5)

14% less capital invested

Capital invested by funds: $4B → $3.46B (-$542M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
214
Holders Change
-5
Holders Change %
-2.28%
% of All Funds
3.29%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
29
Increased
76
Reduced
69
Closed
32
Calls
$6.41M
Puts
$1.18M
Net Calls
+$5.23M
Net Calls Change
+$2.83M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$56.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$35M
3
NAMA
Nikko Asset Management Americas
New York
+$34.7M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$34.7M
5
AIM
ARK Investment Management
Florida
+$25.8M

Top Sellers

1
GGHC
Gilder Gagnon Howe & Co
New York
-$31.5M
2
CC
Casdin Capital
New York
-$13.5M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$13.2M
4
BAMCO Inc
BAMCO Inc
New York
-$12M
5
DP
DDD Partners
Washington
-$10.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$842M – – –
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$373M +$56.4M +1,840,491 +16%
MCMC
3
Matrix Capital Management Company
New Hampshire
$325M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$310M +$1.24M +40,615 +0.4%
AIM
5
ARK Investment Management
Florida
$160M +$25.8M +841,447 +17%
BlackRock
6
BlackRock
New York
$153M -$3.69M -120,237 -2%
Sumitomo Mitsui Trust Group
7
Sumitomo Mitsui Trust Group
Japan
$89.7M +$34.7M +1,133,445 +55%
NAMA
8
Nikko Asset Management Americas
New York
$87.1M +$34.7M +1,133,445 +56%
Massachusetts Financial Services
9
Massachusetts Financial Services
Massachusetts
$68.1M +$6.43M +209,731 +9%
Capital International Investors
10
Capital International Investors
California
$58.8M – – –
Neuberger Berman Group
11
Neuberger Berman Group
New York
$56.1M -$7.7M -251,084 -11%
BG
12
Bellevue Group
Switzerland
$55.2M +$19.4M +632,408 +47%
State Street
13
State Street
Massachusetts
$45.8M +$3.22M +105,132 +7%
Invesco
14
Invesco
Georgia
$43.5M +$1.12M +36,538 +2%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$40.4M +$1.42M +46,431 +3%
Goldman Sachs
16
Goldman Sachs
New York
$37M +$1.47M +47,975 +4%
Lazard Asset Management
17
Lazard Asset Management
New York
$34.8M +$2.12M +69,230 +6%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$32.1M +$35M +1,143,169 +89,101%
TM
19
Tiger Management
New York
$31.3M – – –
Norges Bank
20
Norges Bank
Norway
$29.1M +$2.11M +68,914 +7%
TCM
21
TimesSquare Capital Management
New York
$28.5M -$1.72M -56,100 -5%
CC
22
Casdin Capital
New York
$28.1M -$13.5M -440,000 -31%
SIG
23
Senator Investment Group
New York
$28.1M – – –
GGHC
24
Gilder Gagnon Howe & Co
New York
$26.5M -$31.5M -1,027,060 -52%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$26.1M -$67K -2,185 -0.2%
1
2 3 4 5

ADPT Hedge Fund Activity: Q4 2021 in Review

214 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q4 2021, worth a combined $3.46B — down 14% from $4B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ADPT and 29 opened new positions — a net loss of 3 holders — while 69 trimmed existing stakes and 76 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $56.4M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $31.5M.

  • 214 institutional investors held Adaptive Biotechnologies (ADPT) as of Q4 2021, down from 219 in Q3 2021.
  • Funds reported $3.46B of Adaptive Biotechnologies stock for Q4 2021, down 14% quarter-over-quarter.
  • 29 funds opened new Adaptive Biotechnologies positions in Q4 2021 and 32 closed out, a net change of -3 holders.
  • The largest Adaptive Biotechnologies buyer in Q4 2021 was T. Rowe Price Associates, an estimated $56.4M added.
  • The largest Adaptive Biotechnologies seller in Q4 2021 was Gilder Gagnon Howe & Co, an estimated $31.5M sold.

Based on aggregated 13F filings for Q4 2021.